C MIDDLE-DISTANT E AND REMOTE E RESULTS OF USING MAGMARIS BVS - FRAMES IN PATIENTS WITH ACUTE CORONARY EVENTS

Authors

  • Yuldoshev N.P Center for the Development of Professional Qualifications of Medical Workers
  • Kholikulov S.Sh Multidisciplinary medical center “Sog`lom Hayot”
  • Yuldosheva Kh.A Samarkand regional branch of the Republican Specialized Scientific and Practical Medical Center of Cardiology. »Tashkent, Uzbekistan
  • Sanakulov Zh.M Samarkand regional branch of the Republican Specialized Scientific and Practical Medical Center of Cardiology. »Tashkent, Uzbekistan
  • Pirmanov Sh.V Samarkand regional branch of the Republican Specialized Scientific and Practical Medical Center of Cardiology. »Tashkent, Uzbekistan

Keywords:

bioresorbable frame, coronary heart disease, acute myocardial infarction

Abstract

To study the mid-term and long-term results of using the new generation M agmaris BVS frame in patients with acute coronary artery disease

References

Campos CM, Muramatsu T, Iqbal J, Zhang YJ, Onuma Y, Garcia-Garcia HM, Haude M, Lemos PA, Warnack B, Serruys PW. 2013. Bioresorbable drug-eluting magnesium-alloy scaffold for treatment of coronary artery disease. Int J Mol . Sci 14:24492–24500.

BIOSOLVE-II first-in-man trial. Eur. Heart J. Haude M, Ince H, Kische S, Abizaid A, Tölg R, Alves Lemos P, van Mieghem NM, Verheye S, Birgelen C von, Christiansen EH, Barbato E, Garcia-Garcia HM, Waksman R. 2018. Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III. Catheter Cardiovasc Interv .

Haude M, Ince H, Kische S, Abizaid A, Tölg R, Alves Lemos P, van Mieghem NM, Verheye S, Birgelen C von, Christiansen EH, Wijns W, Garcia-Garcia HM, Waksman R. 2017. Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: Pooled outcomes of BIOSOLVE-II and BIOSOLVE-III. EuroIntervention .

Johan Bennett, Alfonso Ielasi , Jan Torzewski, Quentin de Hemptinne , Enrico Cerrato, Magdalena Lanocha , Stefano Galli, Manel Sabaté . The Resorbable Magnesium Scaffold Magmaris in Acute Coronary Syndrome: An Appraisal of Evidence and User Group Guidance. // Cardiovascular Revascularization Medicine. Vol.39, June 2022, P.106-113 // https://doi.org/10.1016/j.carrev.2021.09.012 .

Valgimigli M, Campo G, Monti M, et al. Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial. Circulation 2012;125:2015 –26.

Schulz- Schüpke S, Byrne RA, Ten Berg JM, et al. ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting. Eur Heart J 2015;36:1252 –63.

Michael J. Lipinski, Ricardo O. Escarcega, Nevin C. Baker, Hadiya A. Benn, Michael A. Gaglia, Rebecca Torguson, and Ron Waksman. Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold: A Systematic Review and Meta-Analysis. // J Am Coll Cardiol Intv . 2016 Jan, 9 (1) 12–24. doi /10.1016/j.jcin.2015.09.024

Downloads

Published

2024-05-09

How to Cite

Yuldoshev N.P, Kholikulov S.Sh, Yuldosheva Kh.A, Sanakulov Zh.M, & Pirmanov Sh.V. (2024). C MIDDLE-DISTANT E AND REMOTE E RESULTS OF USING MAGMARIS BVS - FRAMES IN PATIENTS WITH ACUTE CORONARY EVENTS. World Bulletin of Public Health, 34, 26-32. Retrieved from https://scholarexpress.net/index.php/wbph/article/view/4147

Issue

Vol. 34 (2024): WBPH

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.